CHAPUIS, J., HANSMANNEL, F., GISTELINCK, M., MOUNIER, A., VAN CAUWENBERGHE, C., KOLEN, K.V., GELLER, F., SOTTEJEAU, Y., HAROLD, D., DOURLEN, P., GRENIER-BOLEY, B., KAMATANI, Y., DELEPINE, B., DEMIAUTTE, F., ZELENIKA, D., ZOMMER, N., HAMDANE, M., BELLENGUEZ, C., DARTIGUES, J.F., HAUW, J.J., LETRONNE, F., AYRAL, A.M., SLEEGERS, K., SCHELLENS, A., BROECK, L.V., ENGELBORGHS, S., DE DEYN, P.P., VANDENBERGHE, R., O'DONOVAN, M., OWEN, M., EPELBAUM, J., MERCKEN, M., KARRAN, E., BANTSCHEFF, M., DREWES, G., JOBERTY, G., CAMPION, D., OCTAVE, J.N., BERR, C., LATHROP, M., CALLAERTS, P., MANN, D., WILLIAMS, J., BUEE, L., DEWACHTER, I., VAN BROECKHOVEN, C., AMOUYEL, P., MOECHARS, D., DERMAUT, B. and LAMBERT, J.C.
(2013)
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
Molecular Psychiatry, 18(11), 1225–1234.